19 November 2017
News and Views
Links and Services
This week's issue of the New England Journal of Medicine compares FOLFIRINOX with gemcitabine for metastatic pancreatic cancer.
Data are lacking on the efficacy and safety of a combination chemotherapy regimen consisting of o
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors